PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Short term Debt (2012 - 2021)

Updated

PharmaCyte Biotech (PMCB) recorded Short term Debt of $66,753 in fiscal Q3 2021 (quarter ended Jan 31, 2021), up 23.4% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Short term Debt (2012 - 2021) Analysis & Trends

At the end of FY2020 (ended Apr 30, 2020), PharmaCyte Biotech reported Short term Debt of $28,918.

  • The fiscal Q3 2021 figure is the highest quarterly Short term Debt since fiscal Q2 2014.
  • Per Business Quant, the preceding three fiscal quarters came in at $54,110 (Q2 2021), $41,498 (Q1 2021) and $28,918 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 66,753.00
Oct 31, 2020 54,110.00
Jul 31, 2020 41,498.00
Apr 30, 2020 28,918.00
Jan 31, 2014 20,000.00
Oct 31, 2013 420,000.00
Jul 31, 2013 420,000.00
Apr 30, 2013 420,000.00
Jan 31, 2013 420,000.00
Oct 31, 2012 420,000.00
Jul 31, 2012 730,000.00
Apr 30, 2012 2.09 Mn
API Access

PharmaCyte Biotech Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PMCB&period=max&api_key=YOUR_API_KEY